A new analysis from the USC Schaeffer Center for Health Policy and Economics warns that overpayments to Medicare Advantage plans now exceed 20% — or $75 billion — per year, underscoring the urgent need for … Read More »
At the USC Roski Eye Institute, researchers Melinda Chang, MD, a pediatric neuro-ophthalmologist and Benjamin Xu, MD, PhD, who specializes in glaucoma, are leading research on the effectiveness of artificial intelligence in the field … Read More »
In a ceremony on the Health Sciences Campus on May 31, Gabriel Zada, MD, director of the USC Brain Tumor Center, was named Keck Medical Center of USC’s Physician of the Year. This was the organization’s inaugural Physician of the … Read More »
On March 10, 2023, Senta Georgia, PhD, of USC Stem Cell, became the first Black PhD scientist to be tenured in the history of the Keck School of Medicine of USC, which was founded … Read More »
A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) faced by Black patients in the United … Read More »
On June 6 and 7, the employee inclusion resource (ERG) group Keck Pride celebrated the start of Pride Month with breakfast events taking place on the Health Sciences Campus and at USC Verdugo Hills Hospital. On Sunday, the ERG led … Read More »
Effective today, Robert (Robbie) Shappley, JD, MBA (Healthcare), will serve as USC Arcadia Hospital’s (USC-AH) new chief operating officer. In a May 31 announcement to the USC-AH staff, President and CEO … Read More »
Eight years after biosimilar drugs were introduced to the prescription drug market, researchers from the USC Schaeffer Center have studied the cancer drug trastuzumab (Herceptin) and five similar medications as an example of biosimilars’ potential … Read More »
The study, led by Leah Stein Duker, PhD, OTR/L, of the USC Chan Division of Occupational Science and Occupational Therapy, in partnership with Children’s Hospital Los Angeles and assisted by … Read More »
The Keck School of Medicine of USC’s Department of Population and Public Health Sciences is set to launch the Fellowship in Continuous Learning for Antiracist Curricular Change, building from a new departmental initiative to embed principles of … Read More »
Next year, Rocco Cavaleri, PhD, head of the Brain Stimulation and Rehabilitation Lab at West Sydney University, will spend four to six months at the Applied Movement and Pain Laboratory — … Read More »
The Simms/Mann Family Foundation has awarded 10 Keck Medicine of USC nurses with a surprise gift of $10,000 each as part of the foundation’s inaugural Off the Chart: Rewarding Nursing Greatness campaign. The award … Read More »
The Keck School of Medicine of USC’s Steven Gazal, PhD, working with researchers from around the world, is part of the first scientific team to precisely identify segments of the human genome that have remained consistent, or … Read More »
The National Institutes of Health (NIH) has awarded the four-year grant to fund a new study led by Zhipeng Lu, PhD, of the Zhipeng Lu Lab, part of the USC Alfred … Read More »
In a recent episode of the video series “Conversations with Rod” — part of Keck Medicine of USC’s Leadership Forum — CEO Rod Hanners sat down with Inderbir Gill, MD, the founding executive director of … Read More »
Kim Carli, MSHS, has been named chief of the office of performance and transformation for Keck Medical Center of USC. She will assume her role on June 6. The announcement was made on May 23 by Keck … Read More »
As the newest member of the USC Health System Board, Paul B. Rothman, MD, will help to provide strategic oversight and governance for Keck Medicine of USC and university clinical services.
Rothman, former CEO of … Read More »
Title IX — the landmark legislation that prohibits sex discrimination in educational institutions that receive federal funding — was signed into law on June 23, 1972. In recognition of this anniversary, the University of California is presenting … Read More »
Only weeks after international, national and local agencies officially declared the end of the COVID-19 pandemic as a health emergency, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences’ Class of 2023 celebrated their commencement … Read More »
Biosimilars provide the same therapeutic benefits at much less cost than biologic medications, but a first-of-its-kind survey led by USC Leonard D. Schaeffer Center for Health Policy and Economics shows that commercial insurers either exclude or limit … Read More »